Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Report Overview
The Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market size was $2.81 billion in 2023. The market will grow at a CAGR of less than 1% during 2023-2033.
Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic. However, if left untreated they can cause pelvic inflammatory disease (PID), which, in turn, can lead to additional complications such as infertility, ectopic pregnancy, and chronic pelvic pain. Chlamydia Trachomatis can be transmitted during anal, oral, or vaginal sex. It can also be passed from a mother to her newborn child during childbirth.
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Outlook, 2023-2033 ($ Billion)
Buy Full Report for More Insights into The Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Forecast
Download a Free Report Sample
The Chlamydia Trachomatis and Neisseria Gonorrhoeae tests market research report explains the market behavior, which will help identify quantitative market trends within the In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on the Chlamydia Trachomatis and Neisseria Gonorrhoeae tests market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.
Market Size (2023) | $2.81 billion |
CAGR (2023-2033) | <1% |
Forecast Period | 2024-2033 |
Historical Period | 2015-2022 |
Key Regions | · North America
· Europe · Asia Pacific · South America · Middle East and Africa |
Key Segments | · Chlamydia Trachomatis Nucleic Acid Amplification Tests (NAATs)
· Dual CT/NG Nucleic Acid Amplification Tests (NAATs) · Neisseria Gonorrhoeae Nucleic Acid Amplification Tests (NAATs) · Other Chlamydia Trachomatis Tests · Other Neisseria Gonorrhoeae Tests |
Leading Companies | · Hologic
· Danaher Corp · F. Hoffmann-La Roche Ltd · Becton Dickinson and Co · Abbott Laboratories |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Dynamics
The Chlamydia trachomatis (CT) tests market is expected to increase during the forecast period, largely due to sales increase in the North American region. In Europe and Asia Pacific, growth is expected to occur in select countries. However, declines in large CT testing markets such as France, the UK, China, and Japan will outweigh the growth.
The increasing prevalence of Chlamydia and opportunistic screening tests provided by healthcare facilities are the major drivers for CT testing in key North American and European markets. Factors that are expected to negatively impact the Chlamydia trachomatis tests market include changes to sexual and reproductive health service provision, switches in device use, and declines in live birth rates.
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Segments
The Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market can be segmented into Chlamydia Trachomatis Nucleic Acid Amplification Tests (NAATs), Dual CT/NG Nucleic Acid Amplification Tests (NAATs), Neisseria Gonorrhoeae Nucleic Acid Amplification Tests (NAATs), Other Chlamydia Trachomatis Tests, and Other Neisseria Gonorrhoeae Tests. Dual CT/NG Nucleic Acid Amplification Tests (NAATs)led the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market in 2023. The segment is expected to lead the market throughout the projected period.
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Analysis by Segments, 2023 (%)
Buy Full Report for More Insights into The Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Segments
Download a Free Report Sample
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Segmentation by Regions
The key regions in the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market are North America, Europe, Asia Pacific, South America, and the Middle East and Africa. In 2023, Asia-Pacific led the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market, followed by Europe. Australia and New Zealand have reported high incidence rates of Chlamydia Trachomatis infections. Due to this, sales of CT testing devices in these countries have been strong. These countries also offer NG screening to pregnant women as a routine practice.
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Insights into The Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Regions
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market - Competitive Landscape
The leading companies in the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market are:
- Hologic
- Danaher Corp
- Hoffmann-La Roche Ltd
- Becton Dickinson and Co
- Abbott Laboratories
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Insights into the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Companies
Download a Free Report Sample
Segments Covered in the Report
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Segments Outlook (Value, $ Billion, 2015-2033)
- Chlamydia Trachomatis Nucleic Acid Amplification Tests (NAATs)
- Dual CT/NG Nucleic Acid Amplification Tests (NAATs)
- Neisseria Gonorrhoeae Nucleic Acid Amplification Tests (NAATs)
- Other Chlamydia Trachomatis Tests
- Other Neisseria Gonorrhoeae Tests
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
Key Inclusions
Key Inclusions of the market model are:
Currently marketed Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests and evolving competitive landscape:
– Insightful review of the key industry trends.
– Annualized total Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market revenue by segment and market outlooks from 2015-2033.
– Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
– Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
– SWOT analysis for the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market.
– Competitive dynamics insights and trends provided for the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
– Country-specific overview of the healthcare system.
– Country-specific reimbursement policies.
– Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc , Danaher Corp, Becton Dickinson and Co ,Hologic Inc, Quidelortho Corp, Bio-Rad Laboratories Inc, Trinity Biotech Plc, ZeptoMetrix Corporation, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
- CMO executives who must have a deep understanding of the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Understand the impact of COVID-19 on the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Abbott Laboratories
Thermo Fisher Scientific Inc
Danaher Corp
Becton Dickinson and Co
Hologic Inc
Quidelortho Corp
Bio-Rad Laboratories Inc
Trinity Biotech Plc
ZeptoMetrix Corporation
Frequently asked questions
-
What was the Chlamydia Trachomatis and Neisseria Gonorrhoeae Test market size in 2023?
The Chlamydia Trachomatis and Neisseria Gonorrhoeae Test market size was valued at $2.81 billion in 2023.
-
What is the expected Chlamydia Trachomatis and Neisseria Gonorrhoeae Test market growth rate for the forecast period?
The Chlamydia Trachomatis and Neisseria Gonorrhoeae Test market will grow at a CAGR of less than 1% during 2023-2033.
-
Which region had the largest share of the Chlamydia Trachomatis and Neisseria Gonorrhoeae Test market in 2023?
Asia-Pacific had the largest Chlamydia Trachomatis and Neisseria Gonorrhoeae Test market share in 2023.
-
Which segment held the largest share of the Chlamydia Trachomatis and Neisseria Gonorrhoeae Test market in 2023?
Dual CT/NG Nucleic Acid Amplification Tests (NAATs) led the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market in 2023.
-
Who are the major players operating in the Chlamydia Trachomatis and Neisseria Gonorrhoeae Test market?
A few of the leading companies in the Chlamydia Trachomatis and Neisseria Gonorrhoeae Test market are Hologic, Danaher Corp, F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, and Abbott Laboratories among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.